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Success of insecticide spraying
in controlling malaria
To the Editor: I would like to bring to your attention the
reduction in malaria incidence in northern KwaZulu-Natal
during the past 2 years, which appears to have been achieved
primarily by effective insecticide house-spraying.
Despite heavy rain in November 2000 (236 mm at
Ingwavuma town), the malaria incidence dropped in December
2000, at a time when it usually increases, and has since
continued to decline sharply.
DDT had been phased out in favour of pyrethroid insecticide
in 1995 and 1996. However, after the discovery of pyrethroid-
resistant, but DDT-sensitive, Anopheles funestus mosquitoes by
K Hargreaves from the Malaria Control Programme at Jozini, 1
DDT was reintroduced during 2000 for house-spraying in
northern KwaZulu-Natal. 
Insecticide house-spraying in southern Mocambique started
in November 2000, as part of the Lubombo Spatial
Development Initiative. 
The introduction in mid-January 2001 of Coartem tablets
(Novartis) (20 mg artemether and 120 mg lumefantrine)2 to
treat malaria has probably further helped to reduce malaria
incidence. The previous regime of sulfadoxine/pyrimethamine
was demonstrated to be ineffective,3 whereas Coartem appears
to be effective.4
By way of example, figures for malaria incidence since 1995
from Ndumo Clinic, Ingwavuma District, northern KwaZulu-
Natal, are set out in Table I.
The loss of malaria control between the years 1996 and 2000
demonstrates the need for constant activity against the
mosquito and a vigilant watch for the emergence of insecticide-
resistant strains.
C H Vaughan Williams
Member of Subcommittee for Chemoprophylaxis and Therapy of the 
Malaria Advisory Group
Mosvold Hospital
P Bag X2211
Ingwavuma
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Recurrent meningitis due to
unrecognised skull fracture
To the Editor: I read with interest the recent ‘Forum’ article
entitled ‘Recurrent meningitis due to unrecognised skull
fracture’.1 As the author points out, the association between
head injury which results in a tear of the dura in relation to a
shared bony wall between the skull base and a paranasal sinus,
and subsequent non-meningococcal meningitis, is well known.
That this injury may be occult and that meningitis can develop
many years after the head injury cannot be overemphasised.
In 1993 Professor V J Farrell and myself published findings
on a series of 30 patients2 admitted with non-meningococcal
meningitis and investigated by us using direct coronal
computed tomography (CT) scanning. A fracture involving a
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Table I. Patients testing positive each month for falciparum malaria at Ndumo Clinic, Ingwavuma District, KwaZulu-Natal, 1995 - 2002
1995 1996 1997 1998 1999 2000 2001 2002
January 51 226 257 538 748 3 397 598 199
February 26 951 136 362 968 4 203 396 147
March 38 1 543 587 326 1 496 7 007 473 67
April 83 755 467 463 1 470 3 683 394 134
May 137 431 255 297 1 760 3 062 1 156 97
June 37 156 102 113 1 309 2 057 144 10
July 44 56 29 112 997 1 241 104 8
August 13 19 14 56 1 673 1 200 89 2
September 10 47 39 74 1 944 1 607 67 7
October 72 71 177 118 1 163 1 563 55 16
November 91 102 189 181 1 274 1 270 49 24
December 35 253 645 332 2 618 595 110 22
Year total 637 4 610 2 897 2 972 17 420 30 885 3 635 733
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paranasal sinus adjacent to the floor of the anterior or middle
cranial fossa (shared bony wall fracture) was demonstrated in
every case. Of the 30 patients, 2 refused surgery. In the other 28
patients surgical exploration was performed and the site of the
fracture corresponded to a site of dural tear in every case. The
image published in Dr Ouma’s article is similar to a number of
the images obtained in our series. The longest interval from the
time of head injury to presentation with non-meningococcal
meningitis in our series was 13 years. Our article was one of
the first publications to document the value of direct coronal
CT scanning in this setting.
In light of the current HIV/AIDS epidemic, patients with
opportunistic intracranial infection would have to be excluded;
otherwise it is my belief that every patient who presents with
non-meningococcal meningitis should be investigated for a
possible shared bony wall fracture by undergoing a direct
coronal CT scan of the floor of the anterior and middle cranial
fossae.
Don Emby
Western Deep Levels Hospital
Western Levels
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Need and opportunities for
training health professionals in
medical genetics
To the Editor: Medical genetics is a subspecialty registrable
with the Health Professions Council of South Africa (HPCSA).
Subspecialty training in medical genetics can be undertaken in
academic centres registered with the HPCSA.
Medical genetics has played an increasing role in health care
over the last half century and the need for medical genetic
services in many developing countries including South Africa
has become apparent in the last decade. Serious birth defects
and genetic disorders comprise a wide-ranging and complex
group of conditions affecting 50 - 80 per 1 000 children in this
country and they contribute significantly to infant mortality
and morbidity. The role of genetics in medicine is set to
increase as the impact of the Human Genome Project and
future developments are brought to bear on the care and
prevention of the chronic common disorders of later life such
as cancer, hypertension, stroke, asthma and mental disorders.
Currently, South Africa boasts 13 registrable clinical
geneticists and fewer genetic counsellors. These personnel are
far too few to bring a reasonable service to the population of
this country. Currently, three departments of human genetics in
South Africa, at the Universities of Cape Town, Free State and
the Witwatersrand, are registered with the HPCSAto provide
sub-specialty training for clinicians in medical genetics.
Unfortunately, because of financial constraints and competing
priorities, posts available to undertake such training are
limited.
The Department of Human Genetics of the National Health
Laboratory Service (NHLS) (Central), based in Johannesburg,
has academic links to the Faculty of Health Sciences, University
of the Witwatersrand, and offers a 2-year training post in the
subspecialty of Medical Genetics for a specialist already
registered in Paediatrics, Obstetrics and Gynaecology or
Internal Medicine. The Colleges of Medicine of South Africa
examine appropriately trained persons for registration and a
Masters degree (Medicine) can be obtained concurrently
through the Faculty of Health Sciences at the University of the
Witwatersrand.
The Foundation for Alcohol Related Research (FARR) is
offering a bursary commensurate with the salary earned by a
specialist in public service to a selected person for training in
Medical Genetics. The position becomes available on 1 January
2003.
A 2-year training in Genetic Counselling (Masters in
Medicine) is also available for successful applicants
commencing 1 January 2003. This is a comprehensive course
similar to training schedules in the USA, Australia and Europe,
and is registrable in South Africa with the HPCSA.
Scholarships from the NHLS and the University of the
Witwatersrand are offered to successful applicants.
Applications for these fields of training can be made to:
Professor Denis Viljoen, National Health Laboratory Service,
PO Box 1038, Johannesburg, 2000. Tel: 011-489 9211, Fax: 011-
489 9226, Email: denis@mail.saimr.wits.ac.za
Denis Viljoen
Department of Human Genetics
National Health Laboratory Service
Johannesburg
Two mutations in the MTHFR
gene associated with mild
hyperhomocysteinaemia
To the Editor: We read with much interest the article by Scholtz
et al.1 on the interethnic differences in frequencies of the C677T
and A1298C mutations of the methylene tetrahydrofolate
reductase (MTHFR) gene. The importance of their findings
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